MedChemExpress BMS-265246 is a potent and selective cyclin-dependent kinase CDK1 and CDK2 inhibitor, with IC50 values of 6 and 9 nM, respectively. BMS-265246 inhibits CHI3L1 (chitinase 3-like-1) stimulation of ACE2 (angiotensin converting enzyme 2) and SPP (viral spike protein priming proteases). BMS-265246 can be used for ovarian cancer and COVID-19 research.

Prissättning och tillgänglighet
Specifikationer

Molekylformel	C₁₈H₁₇F₂N₃O₂
Rekommenderad förvaring	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Formel vikt	345.34
Hållbarhet	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Löslighetsinformation	DMSO : 12.5 mg/mL (36.20 mM; Need ultrasonic)
Anteckningar om renhetsgrad	Research
Fysisk form	Solid
Kvalitet	Research
Färg	Pink
CAS	582315-72-8
LEDER	CC1=CC(F)=C(C(C2=CN=C(NN=C3)C3=C2OCCCC)=O)C(F)=C1
Molekylvikt (g/mol)	345.34
Kemiskt namn eller material	BMS-265246
Procent renhet	98.64%
För användning med (applikation)	Cancer-Kinase/protease

CAS RN 582315-72-8

Filtrerade sökresultat

Begränsa resultat

Tocris Bioscience™ BMS 265246, >97% Greener Choice ProductThis product offers one or more environmental benefits itemized in the U.S. FTC “Green Guides.”Learn More About the Greener Choice Program

Tocris Bioscience™ BMS 265246, >97%